Skip to main content
. 2021 Jun 29;2021(6):CD004011. doi: 10.1002/14651858.CD004011.pub4

Summary of findings 4. Removal of short‐term indwelling urethral catheters in adults: prophylactic use of alpha blocker versus no drug or intervention.

Removal of short‐term indwelling urethral catheters in adults: prophylactic use of alpha blocker versus no drug or intervention
Patient or population: adults with short‐term indwelling urethral catheters that need to be removed
Settings: secondary care
Intervention: prophylactic use of alpha blocker
Comparison: no drug or intervention
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI) № of participants
(trials) Certainty of the evidence
(GRADE) Comments
Assumed risk Corresponding risk
Risk with no alpha blocker Risk with prophylactic alpha blocker
Number of participants requiring recatheterisation Trial population RR 1.18 
(0.58 to 2.42) 184
(2 RCTs) ⊕⊝⊝⊝
Very lowa,b  
120 per 1000 141 per 1000
(69 to 289)
Symptomatic catheter associated urinary tract infection Trial population RR 0.20
(0.01 to 4.06)
94
(1 RCT) ⊕⊝⊝⊝
Very lowa,b  
43 per 1000 9 per 1000
(0 to 173)
Dysuria Not reported
Condition‐specific QoL or generic QoL measure Not reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: confidence interval; IUC: indwelling urethral catheter; QoL: quality of life; RCT: randomised controlled trial; RR: risk ratio
GRADE Working Group grades of evidenceHigh certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
Low certainty: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

aDowngraded one level for risk of bias (unclear random sequence generation, allocation concealment and blinding of outcome assessors).
bDowngraded two levels for imprecision: few participants and wide 95% confidence interval that is consistent with possible benefit and possible harm.